Follow a curation of discoveries and updates in immunology focusing on immune responses to infectious disease, structure and function, and developments in the defense against infection by watching and engaging in these webinars.
Several SARS-CoV-2 variants are circulating globally. The most prominent variants of concern, including the B.1.1.7, B.1.351 and B1.1.28 lineages, not only carry a constellation of genetic m...
The coronavirus SARS-CoV-2 has led to a worldwide pandemic. Beside respiratory symptoms, infected people may develop neurologic dysfunctions such as loss of smell and taste, also seizures, a...
The ongoing unprecedented outbreak of pneumonia caused by a novel coronavirus (SARS-CoV-2) in Wuhan, China has highlighted the necessity for readily available, accurate and rapid diagnostic...
Join us for an enlightening session on the latest advancements in organoid research and drug discovery! Discover transformative applications, emerging trends, and common challenges in organo...
In this third and final part of our translational cell and gene therapy webinar series we delve into cell therapy applications beyond immune oncology. Firstly, we will look into Miltenyi Bio...
BGI group has been at the forefront in the fight against covid-19. Starting from building a lab in Wuhan, sequencing first 2019-nCoV virus genome and offering RT-PCR and sequencing based det...
Learning Objectives: 1. What kind of virus is the coronavirus? Where is its greatest vulnerability and why? 2. What differentiated the HCoVs discovered in the 1960s from the SARS-CoV and MER...
Problem Measuring viscosity is critical to knowing if your protein and formulation will be well-behaved, or if they will really disrupt the flow of things during administration. Too bad most...
As the spread of infectious diseases, current pandemic, and growing antimicrobial resistance (AMR) continues globally, next-generation sequencing (NGS) became a tool to diagnose infectious d...
With more than 6 million infections and more than 300,000 deaths (as of end of May 2020), the current COVID-19 pandemic has led to large scale lockdown around the world to prevent further sp...
Next-generation sequencing (NGS) is the primary technology used to identify genomic targets for vaccine development. Enhanced options for NGS on Illumina systems now make it possible to iden...
DATE: December 11, 2018TIME: 11:00 PSTThis webinar will focus on how Reichert's Surface Plasmon Resonance (SPR) systems can generate additional valuable information that is not...
Cell therapy holds promise in improving outcomes for many difficult-to-treat diseases. However, this therapeutic strategy also comes with challenges that limit rollouts on a more impactful s...
Differences in how users gate populations within experiments are major sources of variability in flow cytometry data analysis. Incorporating automated image analysis can substantially reduce...
Sean Taylor will be presenting on the following: Title: COVID-19 infection mechanism, rate of infection and tools for testing and monitoring the disease spread Abstract:Since COVID-19 was fi...
The COVID-19 pandemic continues to have a grip on worldwide health and global economics. Advancing molecular diagnostics is central to the diagnosis and prevention efforts surrounding the de...
Even as COVID-19 vaccines are being deployed around the world, the clinical laboratory will continue to play a major role this year helping to control the pandemic by diagnosing new infectio...
El cáncer de ovario sigue siendo un desafío importante para la salud de las mujeres, con altas tasas de mortalidad debido al diagnóstico en etapa tardía. Este sem...
The COVID-19 pandemic has resulted in demand for population scale pathogen screening. The most sensitive and reliable method for detecting SARS-CoV-2 remains reverse transcription PCR (RT-PC...
The Year of Rat is unfortunately dominated by bats due to the COVID-19 outbreak. Although we are not 100% certain that this is a bat virus, all the evidence suggests that there is a high cha...
As the COVID-19 pandemic continues, SARS-CoV-2 molecular testing continues to play a central role managing patient care and supporting epidemiological studies or developing new anti-virals a...
Severe COVID-19 is characterized by dramatic immune system activation and inflammation. Several studies to modulate the immune response and limit immunopathology are ongoing. To better under...
Dr. Jordan RoseFigura from Swift Biosciences will present on the technology created to enable this research that covers 99.7 % of the SARS-CoV-2 genome from limited viral titers. Including a...
When SARS-CoV-2 reached the United States in late January 2020, Labcorp immediately began development of an RT-PCR test to aid in detection and diagnosis of COVID-19 in infected patients. As...
I will discuss the development of the “Midnight” panel for faster, simpler, and less expensive SARS-CoV-2 genome sequencing. We show that using a multiplexed set of primers in co...
Several SARS-CoV-2 variants are circulating globally. The most prominent variants of concern, including the B.1.1.7, B.1.351 and B1.1.28 lineages, not only carry a constellation of genetic m...
